HIGHLIGHTS
- who: Andrila E. Collins and colleagues from the Department of Biomedical Sciences and Collaborative Specialization in Neuroscience Program, University of Guelph, Guelph, ON N G , Canada have published the research: VANL-100 Attenuates Beta-Amyloid-Induced Toxicity in SH-SY5Y Cells, in the Journal: (JOURNAL)
- what: The aim of this study was to assess the cytoprotective effects of the novel antioxidant compound VANL-100 in a cellular model of beta-amyloid (Au03b2)-induced toxicity. For this study, a co-drug is defined as Prior to testingdrug the neuroprotective effects of the antioxidant the toxicithe conjugated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.